This inventor holds 4 USPTO granted patents. Top assignee: Pierre Fabre Medicament. Active years: 2008-2013.
Company Filing History:
Years Active: 2008-2013
Title: Roland Segonds: Innovator in Pharmaceutical Composition
Introduction
Roland Segonds is a notable inventor based in Toulouse, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compositions involving idazoxan. With a total of 4 patents to his name, Segonds continues to impact the medical industry with his research and developments.
Latest Patents
Segonds' latest patents include a pharmaceutical composition based on idazoxan, which encompasses its salts, hydrates, or polymorphs. One of his notable inventions is a pharmaceutical composition that comprises idazoxan or its derivatives along with their therapeutically acceptable salts, racemates, optically active isomers, and polymorphs. Another significant patent details a composition that includes 5 to 20% of an idazoxan salt or hydrate, 10 to 40% of microcrystalline cellulose, 1 to 5% of lubricant, 0.1 to 0.5% of colloidal silica, and from 29.5% to 84.8% of lactose, relative to the total mass.
Career Highlights
Segonds is currently associated with Pierre Fabre Medicament, a company known for its commitment to innovation in healthcare. His work at this organization has allowed him to explore and develop new pharmaceutical solutions that address various medical needs.
Collaborations
Throughout his career, Segonds has collaborated with esteemed colleagues such as Jean-Louis Avan and Joël Bougaret. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Roland Segonds stands out as a prominent figure in the pharmaceutical industry, with a focus on innovative compositions that leverage idazoxan. His contributions through patents and collaborations continue to shape advancements in medical treatments.